BLOG

Bloomberg_Intelligence_Vanguards_Of_Health

Vanguards of Health Care by Bloomberg Intelligence: Elicio’s Broad Cancer-Vaccine Ambitions on Apple Podcasts

Initial clinical trial data highlight the potential for a new approach to cancer vaccines to treat patients with a wide range of KRAS mutations, Elicio Therapeutics CEO Robert Connelly explains.